相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
Solrun Vidarsdottir et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Comparison of two different actigraphs with polysomnography in healthy young subjects
Lorenzo Tonetti et al.
CHRONOBIOLOGY INTERNATIONAL (2008)
Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective study
P. Oriot et al.
DIABETES & METABOLISM (2008)
Effect of antipsychotics on peptides involved in energy balance in drug-naive, psychotic patients after 1 year of treatment
Rocio Perez-Iglesias et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
Othman Sentissi et al.
SCHIZOPHRENIA BULLETIN (2008)
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
Gail L. Daumit et al.
SCHIZOPHRENIA RESEARCH (2008)
Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis
Helliner S. Vestri et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors
JL Roerig et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Metabolic efficiency and energy expenditure during short-term overfeeding
AMCP Joosen et al.
PHYSIOLOGY & BEHAVIOR (2005)
Atypical antipsychotics and glucose homeostasis
RN Bergman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Drug induced weight gain, an impediment to successful pharmacotherapy:: Focus on antipsychotics
T Baptista et al.
CURRENT DRUG TARGETS (2004)
Plasma glucose measurement with the Yellow Springs Glucose 2300 STAT and the Olympus AU640
PJ Twomey
JOURNAL OF CLINICAL PATHOLOGY (2004)
Metabolic risk during antipsychotic treatment
JW Newcomer
CLINICAL THERAPEUTICS (2004)
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo
MO Sowell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine
D Gothelf et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Decrease of energy expenditure causes weight increase in olanzapine treatment - A case study
M Virkkunen et al.
PHARMACOPSYCHIATRY (2002)
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone
BR Basson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
DC Henderson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
